Stefan Glombitza
Management
Formycon
Germany
Biography
Stefan Glombitza has more than twenty years of extensive experience in the pharmaceutical industry and has particular expertise in the generics sector. After studying pharmacy at the University of Regensburg and subsequently gaining his PhD, he began his professional career in 1995 as Medical Affairs Manager at Hexal AG. After two years as Head of the Medical Department, he established a project management system in the development area and ultimately was appointed to the Management Board of Hexal Pharmaforschung as Head of Project Management. With the takeover by Novartis in 2005, Dr. Glombitza’s remit expanded to cover leadership of global project and portfolio management within Sandoz’s generics division. After several years in this role he switched to the German business organization to set up the new cross-functional unit Pharmaceutical Affairs. He headed up this business until 2013, when he became Head of the global development center at the Austrian sites of Kundl and Schaftenau. Since October 2016 Stefan Glombitza is Chief Operating Officer (COO) at Formycon. In this role he is responsible for the development operations.
Research Interest
Pharmaceutical Science
